0 CHECKOUT

PRODUCT FILTERS

REGION

PRICE

3
8
8
9

PUBLISHED

1
1
2
9

PRODUCT TYPE

6
2
1

Pharmacoeconomics

The term Pharmaeconomics describes a scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is not just an effective way to analyse and measure the pharmaceutical industry, but also for industry players to gain a competitive advantage and new market entrants to accurately identify where the best commercial opportunities lie.

Whether by cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis or cost-utility analysis, the reports, books, and journals listed under in Research and Markets’ Pharmaeconomics category enable buyers to more accurately apply pharmaeconomics, and to study case histories of these principles put into effective real life action by pharmaceutical companies.

From academic books that introduce students to a set of analytical tools of economic evaluations and their applications in the health sector to special reports covering every aspect of the drug development pipeline (from production and pricing to reviewing portfolios), you will find in this section the information resource that you need. Show Less
Read more

Pharmacoeconomics and Therapeutic Pathways (Farmacoeconomia e percorsi terapeutici)

‘Therapeutic and Long-Distance Pharmaceutical Economics' (‘Farmeconomia e Percorsi terapeutici') is a quarterly review -- online, independent and peer-reviewed It is aimed at students of pharmaceutical...

Published:  May 2016
Price: 

Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity

This report discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances. It also examines preference by deal type, along with disclosed deal...

Published:  October 2015
Price:  From

The Path to Product Inclusion in Clinical Guidelines: Strategies for Success

Clinical guidelines are taking hold in the practice of medicine Though not always voluntarily followed in real-world patient care, they increasingly form the basis of formulary and reimbursement decisions,...

Published:  February 2013
Price:  From

Closing the Loop: delivering real-world commercial benefit from closed-loop marketing

Over the past decade, closed loop marketing (CLM) has been a buzzword in pharma marketing Yet few companies employing it exploit its full potential, stymied by regulatory bottlenecks, cost, delays to...

Published:  January 2013
Price:  From

The Rise of Health Outcome Liaison Teams

When it comes to market access, the payers hold the cards However, in recent years, pharma companies in the US and Europe have found that a Health Outcome Liaison resource has helped evolve a transactional,...

Published:  November 2012
Price:  From

Managing Real World Data

Pharma companies are no longer the sole owners and controllers of the information that determines the maintenance and reimbursement of their products An outpouring of real-world data (RWD) from every...

Published:  October 2012
Price:  From

Advisory Committees and Speaker Bureaux - Ensuring Compliance

Pharma is faced with increasing constraints on physician participation in its advisory board and speaker bureau programs The Physician Payment Sunshine Act, which goes into effect in the US in 2013,...

Published:  October 2012
Price:  From

Pharmacoeconomics: Basic Principles (Farmacoeconomia: Principi di base)

Economic issues related to the health sector have been gaining much attention in recent years, and the challenge of providing quality and comprehensive healthcare to a growing population has become...

Published:  November 2010
Price:  From

Pharmacoeconomics and Outcome Assessment - A Global Issue

Spurred on by requirements for pharmaceutical companies to demonstrate value for money from healthcare intervention, the pharmaceutical industry is having to increase its activities in the economic...

Published:  January 1999
Price: 
Loading Indicator

Our Clients